Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
NCT01323959
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
212
Enrollment
INDUSTRY
Sponsor class
Conditions
Acellular Pertussis
Poliomyelitis
Diphtheria
Tetanus
Interventions
BIOLOGICAL:
BoostrixTM Polio
Sponsor
GlaxoSmithKline